Skip to main content

Balyasny Asset Management L.P.

Position in BBIO — BridgeBio Pharma, Inc.

CIK 1218710 Chicago, IL

Position in BBIO

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$25,998,128
+$8,069,714 QoQ
Shares Held
350,096
+49.4% QoQ
Ownership
0.179%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2020
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BBIO Over Time

Shares Held

Position Value (USD)

Derivatives in BBIO

reported options exposure · as of Dec 31, 2025
CallValue
$6,975,888
CallShares
91,200
PutValue
$940,827
PutShares
12,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Balyasny Asset Management L.P. holds $2,162,785,356 across 177 Biotechnology names. BBIO ranks #24 (1.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in BBIO

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $25,998,128 350,096
2025-12-31 $940,827 12,300
2025-12-31 $17,928,414 234,389
2025-12-31 $6,975,888 91,200
2025-09-30 $638,862 12,300
2025-09-30 $52,702,323 1,014,677
2025-09-30 $5,375,790 103,500
2025-06-30 $3,851,656 89,200
2025-06-30 $548,386 12,700
2025-06-30 $70,885,151 1,641,620
2025-03-31 $439,039 12,700
2025-03-31 $27,658,592 800,075
2025-03-31 $670,658 19,400
2024-09-30 $504,108 19,800
2024-09-30 $1,779,654 69,900
2024-09-30 $13,208,800 518,806
2024-06-30 $5,250,402 207,280
2023-03-31 $3,649,092 220,090
2022-09-30 $248,500 25,000
2022-03-31 $373,377 36,786
2021-12-31 $812,316 48,700
2020-12-31 $3,555,500 50,000